Cited by 787Cellular transport and secretionSystemic Lupus Erythematosus ResearchAutophagy in Disease and Therapy

A lipid associated with the antiphospholipid syndrome regulates endosome structure and function

Kobayashi, Toshihide, Stang, Espen, Fang, Karen S., de Moerloose, Philippe, Parton, Robert G., Gruenberg, Jean·1998·Nature

Abstract

Little is known about the structure and function of membrane domains in the vacuolar apparatus of animal cells. A unique feature of late endosomes, which are part of the pathway that leads to lysosomes, is that they contain a complex system of poorly characterized internal membranes in their lumen. These endosomes are therefore known as multivesicular or multilamellar organelles. Some proteins distribute preferentially within these internal membranes, whereas others are exclusively localized to the organelle's limiting membrane. The composition and function of this membrane system are poorly understood. Here we show that these internal membranes contain large amounts of a unique lipid, and thus form specialized domains within endosomes. These specialized domains are involved in sorting the multifunctional receptor for insulin-like growth factor 2 and ligands bearing mannose-6-phosphate, in particular lysosomal enzymes. We also show that this unique lipid is a specific antigen for human antibodies associated with the antiphospholipid syndrome. These antibodies may act intracellularly by altering the protein-sorting functions of endosomes.

Integrity signals

Registry

Crossref · 10.1038/32440

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Lyso-biphosphatidic acids are key lipids of late endosomes/phagosomes and terminal phospholipid degradation products.

    “Lyso-biphosphatidic acids (LBPA) are key lipids of late endosomes/phagosomes and terminal phospholipid degradation products (44).”

    From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [44]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kobayashi, T., Stang, E., Fang, K. S., de Moerloose, P., Parton, R. G., & Gruenberg, J.
Affiliations
  • University of Geneva (CH)
  • The University of Queensland (AU)
Corresponding author
Gruenberg, Jean
Venue
Nature
Published
1998-03
Volume
392
Issue
6672
Pages
193-197
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1495951828
Cited by
787
References
32
Citations by year
2026: 15 · 2025: 15 · 2024: 17 · 2023: 24 · 2022: 20 · 2021: 21 · 2020: 30 · 2019: 15 · 2018: 24 · 2017: 20 · 2016: 23 · 2015: 16 · 2014: 27 · 2013: 22 · 2012: 19
FWCI
17.99
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
Keywords
antiphospholipid syndrome, lipid rafts, multivesicular endosomes, late endosomes, mannose 6-phosphate receptor, IGF2R, lysosomal enzyme sorting, lysosomal enzymes, protein sorting
MeSH terms
Animals, Antibodies, Monoclonal, Biological Transport, Cell Line, Cricetinae, Humans, Intracellular Membranes, Lipids, Lysophospholipids, Membrane Glycoproteins, Endosomes, Antigens, CD, Antiphospholipid Syndrome, Receptor, IGF Type 2, Monoglycerides, Lysosomal Membrane Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review